Searle & Co. Takeda Pharmaceutical CO LTD Transaction History

Searle & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$13.12 - $15.03 $415,864 - $476,405	-31,697 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$13.54 - $15.35 $947 - $1,074	-70 Reduced 0.22%	31,697 $454,000
Q2 2021 Jul 29, 2021	SELL	$16.55 - $18.64 $27,158 - $30,588	-1,641 Reduced 4.91%	31,767 $535,000
Q1 2021 May 12, 2021	SELL	$16.71 - $19.9 $58,869 - $70,107	-3,523 Reduced 9.54%	33,408 $610,000
Q4 2020 Feb 04, 2021	BUY	$15.39 - $18.97 $1,077 - $1,327	70 Added 0.19%	36,931 $672,000

Q4 2019 Jan 21, 2020	SELL	$16.88 - $20.83 $2,835 - $3,499	-168 Reduced 0.45%	36,861 $727,000
Q3 2019 Oct 22, 2019	SELL	$16.15 - $17.99 $2,697 - $3,004	-167 Reduced 0.45%	37,029 $637,000
Q1 2019 Apr 22, 2019	BUY	$16.7 - $21.52 $621,173 - $800,457	37,196 New	37,196 $758,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

Stay updated on Searle & Co. with notifications on news.